Although there are numerous risk factors for venous thromboembolic dis
ease, the term 'thrombophilia' refers only to those familial or acquir
ed disorders of the haemostatic system that result in an increased ris
k of thrombosis. The inherited thrombophilias include antithrombin III
deficiency, resistance to activated protein C (factor V Leiden), prot
ein C and protein S deficiencies as well as some rare forms of dysfibr
inogenaemia. It is possible that other inherited conditions might also
predispose to thrombosis. In contrast, when using the above definitio
n, the antiphospholipid syndrome is the only genuine acquired thrombop
hilic state. Patients who have thromboembolic disease ata young age wi
th no provoking event or who have a positive family history or whose t
hrombosis involves an unusual site should be investigated for thrombop
hilia. The management of a patient identified as having a laboratory a
bnormality associated with thrombophilia will depend on a variety of f
actors such as the patient's individual and family thrombotic history,
the site of the thrombosis and the presence of other prothrombotic ri
sk factors. The use of prophylactic anticoagulation during pregnancy a
nd the puerperium requires particularly careful consideration in throm
bophilic women. As more becomes known about the thrombophilias it will
become possible to formulate more exact guidelines as to the manageme
nt of these conditions.